Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts
- 1 May 1994
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 106 (5) , 1333-1341
- https://doi.org/10.1016/0016-5085(94)90027-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosisJournal of Hepatology, 1993
- Ursodeoxycholate has no beneficial effect on liver function or histology in biliary cirrhosis in the ratJournal of Hepatology, 1992
- Ursodeoxycholic acid in chronic liver disease.Gut, 1991
- Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1990
- Ursodeoxycholic acid for primary sclerosing cholangitisJournal of Hepatology, 1990
- Ursodeoxycholic acid treatment for chronic cholestatic liver diseaseJournal of Hepatology, 1990
- The order of hepatic cytotoxicity of bile salts in vitro does not agree with that examined in vivo in ratsLife Sciences, 1990
- Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acidsMedical Hypotheses, 1986
- Tauroursodeoxycholate prevents taurocholate induced cholestasisLife Sciences, 1982
- Choleretic and cholestatic effects of infused bile salts in the ratCellular and Molecular Life Sciences, 1979